(107) Validation of an EVLP Perfusate Diagnostic Test for the Prediction of Lung Transplant OutcomesAndrew Sage, PhD
(108) A Clinical Trial Evaluating the Effects of Ultra-Violet C treatment (UVC) during Ex Vivo Lung Perfusion (EVLP) as a Method of Inactivating Hepatitis C Infection in Donor LungsMarcelo Cypel, MD
(109) Stratification Risk Analysis in Bridging Patients to Lung Transplant on ECMO: The STABLE Recipient Risk ScoreAndreas Habertheuer, M.D., Ph.D.
(110) Ex-Vivo Lung Perfusion Mediated Delivery of Rituximab to Clear Latent Epstein-Barr VirusTerrance Ku, BSc
(111) Early Outcomes with the Use of ExtraCorporeal Membrane Oxygenation as a Bridge to Combined Heart and Lung TransplantFederico Sertic, MD
(112) Increasing Use of EVLP in the United States: Data from the OPTN/UNOSRebecca Lehman, PhD
(113) Central Ambulatory Veno-Arterial Extracorporeal Membrane Oxygenation in Lung TransplantationPeter Downey, MD
You must be logged in and own this session in order to